897
Views
14
CrossRef citations to date
0
Altmetric
Letters to the Editor

Motesanib diphosphate (AMG 706), an oral angiogenesis inhibitor, demonstrates clinical efficacy in advanced thymoma

, , , , &
Pages 619-621 | Received 07 Aug 2008, Published online: 08 Jul 2009

Figures & data

Figure 1.  CT scans done at baseline (7/6/07) and after 17 cycles (26-5-08) of treatment with motesanib diphosphate showing reduction in pleurally-based masses.

Figure 1.  CT scans done at baseline (7/6/07) and after 17 cycles (26-5-08) of treatment with motesanib diphosphate showing reduction in pleurally-based masses.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.